BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Zilebesiran readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Zilebesiran\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07181109-532@assetmemo.bio
DTSTAMP:20261121T005620Z
DTSTART;VALUE=DATE:20300923
DTEND;VALUE=DATE:20300924
SUMMARY:Zilebesiran: Phase 3 readout est. (NCT07181109)
DESCRIPTION:Zilebesiran\, phase 3\, Hypertension.\nStudy: Zilebesiran in Pa
 tients With Hypertension Not Adequately Controlled and With Either Establi
 shed Cardiovascular Disease or High Risk for Cardiovascular Disease\nEstim
 ated primary completion: 23 September 2030. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/zilebesiran#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT07181109
URL:https://assetmemo.bio/drug/zilebesiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
